Orchid BioSciences(Princeton, New Jersey), a leading global provider of identity DNA testing services, said that it is seeking stockholder approval to change its name to Orchid Cellmark Inc. The company said it believes that the new name more accurately reflects its current and expected future position as a leader in the provision of DNA identity testing services.

Orchid has filed a preliminary proxy statement regarding the name change with the Securities and Exchange Commission. The proposal will be considered at Orchid’s annual shareholders meeting June 8.